8-K
Current Report
Taysha Gene Therapies, Inc. Filed Acc 0001193125-20-291719
Acquisition or sale completed
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading d71631d8k.htm…